Upcoming Webinars Archived Webinars Training Vitals Host A Webinar About Get Updates Contact

Wrigley Expansion Mirrors Growth Of Confectionary Food Brand

XTALKS VITALS NEWS

Skittles

The new factory space will include a production line for the company’s Skittles product, and will increase the plant’s workforce by 25 percent.

Share this!

June 20, 2016 | by Sarah Massey, M.Sc.

Last week, confectionary company Wrigley, a subsidiary of Mars Incorporated, opened a new addition to its manufacturing facility in Yorkville, Illinois, USA. The 145,000 square foot addition is the result of a $50 million investment by its parent company, Mars.

Tweet: Mars spends $50 million on Yorkville #foodmanufacturing plant http://ctt.ec/4bMod+

The new factory space will include a production line for the company’s Skittles product, and will increase the plant’s workforce by 25 percent. Skittles are now the number one non-chocolate confectionary brand in the US – a fact which was a key driver of the Yorkville expansion.

“Mars has a long-standing history of making our products in the markets where they're sold,” said Casey Keller, President of Wrigley Americas. “With the expansion of our Skittles production footprint, we are proud to continue that tradition right here in the state that Wrigley has called home for 125 years.”

Wrigley attributes the growth of the Skittles brand to “best-in-class marketing, retail activity, innovation and passionate fans.” The newly-renovated Yorkville facility also manufactures other Mars products including Life Savers®, Doublemint® and Juicy Fruit®.



“We are grateful for the support of our state and local communities, which have been instrumental in helping to bring this project to life,” said Keller. “We're fortunate to be able to further invest here in Yorkville, and provide the community with continued economic development.”

Over the past five years, Mars has been expanding rapidly, investing $1 billion in new and improved US manufacturing facilities and creating over 1,000 new jobs. The company plans to invest an additional $900 million in operations expansions and personnel training over the next 2 years.

“Wrigley is an iconic Illinois company, and we are proud it is continuing to grow in our state,” said Illinois Governor Bruce Rauner. “Wrigley has invested nearly $200 million in Illinois over the past seven years, creating hundreds of jobs for Illinois residents. The State of Illinois is glad to be a partner in Wrigley's further expansion.”


Keywords: Food, Food Manufacturing, Food Industry


| NEXT ARTICLE | MORE NEWS | BLOGS | VIDEOS | POLLS & QUIZZES | WEBINARS |

Share this with your colleagues!

MORE NEWS
Insurance Coverage Under the Affordable Care Act Supports Clinical Trial Enrollment, Says Study

July 20, 2017 - Since the Patient Protection and Affordable Care Act (ACA) was passed in 2010, insurance approval for patients wishing to participate in oncology clinical trials has increased, according to a recent study published in the journal, Clinical Cancer Research.

Featured In: Clinical Trial News


FDA Approves Puma Biotechnology’s Extended Adjuvant Therapy for Breast

July 19, 2017 - Puma Biotechnology’s breast cancer drug Nerlynx (neratinib) has been approved by the US Food and Drug Administration (FDA).

Featured In: Biotech News


CAR-T Cell Therapy Shows Promise as Leukemia Treatment in Early Stage Clinical Trial

July 19, 2017 - About 70 percent of clinical trial participants with chronic lymphocytic leukemia experienced tumor shrinkage after being treated with CAR-T immunotherapy, according to researchers at Fred Hutchinson Cancer Research Center.

Featured In: Clinical Trial News


LEAVE A COMMENT
 
  
THE XTALKS VITALS INDUSTRY BLOG

Manufacturing Control Strategies: What Pharmaceutical and Biotech Companies Need to Know

REGISTER FOR THESE WEBINARS

Outsourcing Pharmacovigilance: Pros and Cons and Lessons Learned


EDC and eSource: Combined for Better Data and Faster Insights


Using Model Reduction to Bridge the Quality Systems Pharmacology-Pharmacometrics Divide


How to Maximize Your Non-GLP Toxicology Studies: A Guide for Optimal Design and Methodology


Copyright © 2016-2017 Honeycomb Worldwide Inc.